A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
Read a Q-and-A with Jasmine May, a fifth-year student in the Medical Scientist Training Program, who studies the pathophysiology of glioblastoma.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
A study published in Cancer Cell revealed the mechanism by which a gene fusion called ETO2-GLIS2 promotes the development of an aggressive form of acute megakaryoblastic leukemia.
A combination of ultrasound and cystoscopy is the most cost-effective approach to detecting cancer in patients who show microscopic amounts of blood in their urine, according to a JAMA Internal Medicine study.
A study sheds new light on the molecular foundations of human acral lentiginous melanoma, a rare sun-shielded melanoma.
OncoSET, the flagship clinical and research program of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, combines oncology with genomic sequencing to provide cutting-edge cancer care personalized for each patient.
Women who underwent autologous breast reconstruction following a mastectomy reported greater psychosocial and sexual well-being than those who chose implant-based reconstruction, according to a study published in the Journal of Clinical Oncology.